In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells

American Journal of Hematology

Volumn 51, Issue 4, 1996, Pages 261-264

  Tosi, Patrizia ^a,b   Visani, Giuseppe ^a   Ottaviani, Emanuela ^a   Manfroi, Silvia ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute lymphoblastic leukemia; BCL 2; Prednisolone

Indexed keywords

PREDNISOLONE; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ASPARAGINASE; BONE MARROW; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, B-CELL, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PREDNISOLONE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0029871463     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199604)51:4<261::AID-AJH2>3.0.CO;2-U     Document Type: Article

References (18)

1. Tsujimoto Y, Cossman J, Jaffe E, Croce C: Involvement of the BCL-2 gene in human follicular lymphoma. Science 228:1440, 1985.
2. Hockenbery DM, Nunez G, Milliman C, Screiber RD, Korsmeyer SJ: BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990.
3. Korsmeyer SJ: BCL-2 inmates a new category of oncogenes: Regulators of cell death. Blood 80.879, 1992.
4. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991.
5. Campos L, Rouault JP, Sabido O, et al: High expression of BCL-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091, 1993.
6. Campana D, Coustan-Smith E, Manabe A, et al: Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of BCL-2 protein. Blood 81:1025, 1993.
7. Miyashita T, Reed JC: BCL-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cell to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407, 1992.
8. Miyashita T, Reed JC: BCL-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993.
9. Coustan-Smith E, McNinch L, Raimondi SC, et al: BCL-2 expression in acute lymphoblastic leukemia (ALL) cells does not influence response to chemotherapy. Blood 84(suppl 1):377a, 1994.
10. Alnemri ES, Fernandes RF, Haldar S, Croce CM, Litwack G: Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B leukemias. Cancer Res 52:491, 1992.
11. Tu Y, Vescio R, Berenson J, Lichtenstein A: Adriamycin and etoposide upregulate BCL-2 expression in multiple myeloma plasma cells. Blood 84(suppl 1):172a, 1994.
12. Pieters R, Huismans DR, Loonen AH, et al: Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 338:399, 1991.
13. Pieters R, Hongo T, Loonen AH: Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia. Br J Cancer 65:691, 1991.
14. Aiello A, Delia D, Borrello MG, et al: Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. Cytometry 13:502, 1992.
15. Mandelli F, Annino L, Vegna ML, et al: GIMEMA ALL 0288: A multicentric study on acute lymphoblastic leukemia. Preliminary results. Leukemia 6(suppl 2):182, 1992.
16. Tosi P, Visani G, Ottaviani E, Manfroi S, Tura S: In vitro prednisone resistance in adult acute lymphoblastic leukemia (ALL). Proc Am Assoc Cancer Res 36:19, 1995.
17. Lauria F, Raspadori D, Ventura MA, et al: High BCL-2 expression in acute myeloid leukemia cells correlate with CD34 positivity and poor clinical outcome. Blood 84(suppl 1):378a, 1994.
18. Preti A, Kantarjian HM: Management of adult acute lymphoblastic leukemia: Present issues and key challenges. J Clin Oncol 12:1312, 1994.